IP Library Granted Patent US 10,358,631
Granted Patent B2
US 10,358,631 · App. 15/812,628 · Granted Jul 23, 2019

Ketoreductase polypeptides for the preparation of phenylephrine

Inventors: Oscar Alvizo (Fremont, CA); Steven J. Collier (Concord, MA); Hans-Georg Joerg Hennemann (Bedburg, DE); Seong Ho Oh (Singapore, SG); Wenjuan Zha (Singapore, SG)
Assignee: Codexis, Inc.
C12N9/0006A61K31/137C12P13/001C12Y101/01184
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,358,631
App. No.
15/812,628
Granted
Jul 23, 2019
Kind
B2
Abstract

The disclosure relates to engineered ketoreductase polypeptides and processes of using the polypeptides for production of phenylephrine.

Claims (17)

1. An engineered polypeptide capable of converting 1-(3-hydroxyphenyl)-2-(methylamino)ethanone to (R)-phenylephrine, wherein the amino acid sequence of the polypeptide has at least 95% identity to SEQ ID NO: 4 and comprises the residue difference C190G and at least one further residue difference at a position of SEQ ID NO: 4 selected from a position corresponding to position 2, 11, 64, 76, 95, 99, 148, 152, 153, 159, 197, 200, 202, 206, and 249.

2. The engineered polypeptide of claim 1 , wherein the at least one further residue difference comprises A202F.

3. The engineered polypeptide of claim 1 , wherein the at least one further residue difference comprises M206C.

4. The engineered polypeptide of claim 1 , wherein the at least one further residue difference comprises V95M.

5. The engineered polypeptide of claim 1 , wherein the amino acid sequence further comprises at least two residue differences selected from V95M, S96L, L147I, A202F, M206C, and Y202F.

6. The engineered polypeptide of claim 1 , wherein the amino acid sequence further comprises the residue differences V95M, A202F, and M206C.

7. The engineered polypeptide of claim 1 , wherein the amino acid sequence comprises the residue differences V95M, C190G, A202F, M206C, and Y249F.

8. The engineered polypeptide of claim 1 , wherein the amino acid sequence comprises the combination of residue differences of any one of SEQ ID NO: 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, or 34 as compared to SEQ ID NO: 2.

9. The engineered polypeptide of claim 1 , wherein the amino acid sequence further comprises at least one residue difference selected from T2S, I11L, A64V, T76I, V95M, S96L,V99L, V148L, T152A, L153M, S159T, D197A, and E200P.

10. The engineered polypeptide of claim 1 , wherein the polypeptide is capable of stereospecifically converting 1-(3-hydroxyphenyl)-2-(methylamino)ethanone to (R)-phenylephrine in a enantiomeric excess of at least 99%.

11. The engineered polypeptide of claim 1 , wherein the polypeptide comprises a sequence selected from the group consisting of SEQ ID NO: 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, and 34.

12. A method for preparing (R)-phenylephrine the method comprising:

contacting a polypeptide of claim 1 , with a mixture comprising a 1-(3-hydroxyphenyl)-2-(methylamino)ethanone substrate and a buffer under reaction conditions suitable to convert 1-(3-hydroxyphenyl)-2-(methylamino)ethanone to (R)-phenylephrine.

13. The method of claim 12 , wherein the reaction conditions comprise a temperature of about 25° C. to about 35° C.

14. The method of claim 13 , wherein the reaction conditions comprise a pH of about 6.5 to about 7.0.

15. The method of claim 12 , wherein the reaction conditions comprise an initial pH of about 7.0 and then adjusting the initial pH to about 6.75 after about 2 hours.

16. The method of claim 12 , wherein the mixture comprises 50% isopropyl alcohol.

Assignments (1)
SECURITY INTEREST Recorded Feb 15, 2024
From: CODEXIS, INC.
To: INNOVATUS LIFE SCIENCES LENDING FUND I, LP, AS COLLATERAL AGENT
Reel/Frame 066600/0650 →
Continuity (4)
Continuation 14755056 · Jun 30, 2015
Division 13390677
Provisional Application 61235324 · Aug 19, 2009
Related Publication 20180066239A1 · Mar 8, 2018
Cited By (1)
US 12,480,100